|
Back to Home » May 2018 News » New Study Results Presented at ASCO Supports DiviTum® for Monitoring Advanced Breast Cancer Treatment - Biovica International AB |
New Study Results Presented at ASCO Supports DiviTum® for Monitoring Advanced Breast Cancer Treatment - Biovica International AB |
May 17, 2018
STOCKHOLM, May 17, 2018 /PRNewswire/ -- The EFECT-study evaluated standard hormonal therapies for women with advanced breast cancer and DiviTum® was used as a non-invasive tool for monitoring therapy response. 244 patients had blood samples analyzed with DiviTum® in a collaboration...
Source URL: https://www.prnewswire.com/news-releases/new-study-results-presented-at-asco-supports-divitum-for-monitoring-advanced-breast-cancer-treatment---biovica-international-ab-300650153.html
|
|
|
|
